Cigna corporation (CI)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Revenues
Premiums

10,840

10,005

9,935

9,803

9,971

9,108

8,994

9,012

8,999

Net investment income

353

355

349

340

346

444

355

352

329

Total revenues

38,469

38,245

38,556

38,819

37,946

14,300

11,457

11,480

11,413

Benefits and expenses
Pharmacy and other service costs

24,190

24,103

24,552

24,963

24,050

3,017

602

613

561

Medical costs and other benefit expenses

8,322

7,889

7,734

7,576

7,620

7,108

6,803

6,845

6,772

Selling, general and administrative expenses

3,398

3,957

3,413

3,380

3,303

3,480

2,872

2,837

2,745

Amortization of acquired intangible assets

498

735

734

737

743

136

48

24

27

Total benefits and expenses

36,408

36,684

36,433

36,656

35,716

13,741

10,325

10,319

10,105

Income from operations

2,061

1,561

2,123

2,163

2,230

559

1,132

1,161

1,308

Interest expense and other

-391

-391

-411

-428

-452

-286

-99

-56

-57

Debt extinguishment costs

-185

-

-

-

0

-

-

-

-

Net realized investment gains (losses)

-88

93

51

23

10

-45

0

-3

-33

Income before income taxes

1,397

1,261

1,763

1,758

1,788

228

1,033

1,102

1,218

Total income taxes

208

277

409

348

416

81

259

294

301

Net income

1,189

984

1,354

1,410

1,372

147

774

808

917

Less: net income attributable to noncontrolling interests

8

7

3

2

4

3

2

2

2

Shareholders’ net income

1,181

977

1,351

1,408

1,368

144

772

806

915

Shareholders’ net income per share
Basic (in dollars per share)

3.19

2.64

3.60

3.73

3.61

0.41

3.18

3.32

3.78

Diluted (in dollars per share)

3.15

2.61

3.57

3.70

3.56

0.39

3.14

3.29

3.72

Pharmacy revenues
Revenues

25,098

25,645

25,987

26,288

25,179

3,257

747

758

717

Fees and other revenues
Revenues

2,178

2,240

2,285

2,388

2,450

1,491

1,361

1,358

1,368